Report of a second serious adverse event in a clinical trial of gene therapy for X-linked severe combined immune deficiency (X-SCID). Position of the European Society of Gene Therapy (ESGT)

J Gene Med. 2003 Mar;5(3):261-2. doi: 10.1002/jgm.390.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Child, Preschool
  • Europe
  • Genetic Therapy / adverse effects*
  • Genetic Therapy / ethics
  • Humans
  • Infant
  • Severe Combined Immunodeficiency / therapy*